Ben Richardson

Please share - I have one free ticket to next week’s #HIC2024 conference! I would love to offer it to a consumer or community representative who: ⭐️is involved with health technology, health services or research design, quality, safety or improvement projects AND 🖤is an Aboriginal or Torres Strait Islander person OR 💜 a person whose involvement is creating access and safety for people who belong to culturally or racially minoritised communities No strings attached - join me and 15 other consumer reps to learn together and take what we learn back to our projects! ✨ ✍️To EOI, comment below and send me a DM with a couple of sentences (written or video) about how you would put your learnings to work, *ASAP* but prior to COB Thursday Aug 1. Please note: - conference registration costs only - does not include funding support for travel or other expenses - that I may select someone with a great EOI before the deadline, to make sure the person has time to make plans

28

3 Comments

This new report on NHS-industry partnerships from The Association of the British Pharmaceutical Industry (ABPI) and NHS Confed is worth a quick flick (and looks beautiful). Partnering with industry is often put in the "too difficult" box - but it doesn't have to be, especially where there is a clear potential benefit to the people we serve. There's some practical tools in here to help NHS organisations work through some of the thornier issues with partnership too. #health #nhs #pharmaceutical https://lnkd.in/eufXvHYq

4

Cracking, insightful post from Gus. This is the level of quality I want on my LinkedIn feed 👏

17

1 Comment

Health care spending in the US is projected to have grown 7.5 percent in 2023, much faster than the nominal GDP growth rate of 6.1 percent, according to the wonks at CMS. About 17.6% of the share of the nation’s economy is now devoted to health spending or about $4.8 trillion. The entire GDP if the UK is about 2.3 trillion pounds or just shy of 3 trillion dollars. https://lnkd.in/eg_yK8yK

5

🎥 Now available on demand: “Best practice real-world evidence approaches to support economic modelling for health technology assessment.” We’re excited to share the recording of this recent webinar, delivered by Mtech Access in collaboration with Delta Hat Limited and Arcturis. This session explores how real-world evidence (RWE) can be leveraged to supplement clinical data and solve common challenges with treatment comparison. It's a must watch for anyone with data gaps in their evidence dossier considering whether RWE is the answer. 📺 Watch on YouTube: https://lnkd.in/etZ3BZu8 📄 Request the slides here: https://lnkd.in/ej92P8hj The Mtech Access and Delta Hat teams continue to collaborate with the experts at Arcturis to help Pharma clients use RWE effectively in health economic modelling and HTA dossiers. To connect with our experts and discuss your requirements, email [email protected] #HTA #economicmodelling #RWE #collaboration #marketaccess #realworldevidence #healtheconomics #RWD #realworlddata

2

Jordan Sollof, reporter at Digital Health News, is joined by Lloyd Price and Mohammad Al-Ubaydli to talk about procurement and why the NHS is so difficult to sell to. https://lnkd.in/eaW4F2hC From their own experience, Price, a healthtech founder, mergers and acquisitions advisor and non-executive director for various digital health companies, and Al-Ubaydli, founder and chief executive of digital health social enterprise, Patients Know Best, shine a light on the main issues that can make selling to the NHS a challenge. The pair discuss success stories of startups which have successfully sold to the NHS, before assessing whether companies and suppliers need to take more care in ensuring they are pitching the right solution to the right organisation. They give their views on whether the NHS procurement process has become overcomplicated, a point raised in a session at Rewired 2024, and speculate whether the forthcoming Procurement Act (which was originally due to come into force in October 2024, but has been delayed until February 2025) will solve some issues and make it easier for those selling in the health technology sector. Finally, the guests predict what they anticipate will happen in the coming months and years, including whether the NHS will become a simpler system as a whole to sell to or if we will still be having the same conversation about difficulties selling in a few years’ time. Guests: Lloyd Price, health tech founder, mergers and acquisitions advisor and non-executive director for various digital health companies Mohammad Al-Ubaydli, founder and chief executive of Patients Know Best #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #Partnerships #VentureCapital #PrivateEquity 

15

1 Comment

In response to the #Darzi report, my position on this was a simple one, that until greater focus is placed on strengthening the understanding of clinical capacity and demand, NHS trusts will not be empowered to make informed decisions about their workforce and digital expenditure…it will be impossible to hit whatever productivity targets the Government set…and patient outcomes will suffer as a result. Forensic level management information is imperative in the decision making process. Often overlooked as an administrative task or put in the, 'too difficult' category, belies the critical nature of it. It is foundational. The lack of it can be viewed as the root cause of multiple issues. Aspirations need to be met with action. The first action, get clarity, understand your resource. This will lead to a number of positive outcomes, potential to reduce contingency spend, knowing where to invest, ensuring safe staffing levels, being more productive, balancing staff wellbeing, rightsizing your services and most importantly improving patient outcomes. Ask yourself this simple question, 'do you know your trust/service resource'? If the answer is no, then action is required. #Darzi #NHS #transformation

2

This week we have published the seventh and eighth of our deliberately positive and optimistic global predictions from our Accelerating the future: Life Sciences and Healthcare predictions 2030 report. The seventh prediction, on 'The convergence of health, wealth and longevity services’, explores how governments, employers, insurers and technology providers are collaborating to address the opportunities and challenges that most countries are experiencing due to an ageing population and an increase in the dependency ratio. Our eighth prediction, 'End-to-end transformation of pharma’s commercial activities', focuses on the impact in 2030 of the digital transformation of the pharma commercial function, and how AI and data-driven insights can optimise operations, enhance customer engagement and improve patient outcomes. Our blog this week highlights the key insights in these two predictions and explores what we can expect the world in 2030 might look and feel like and hopefully encourages you to discuss among your teams to decide what actions might be needed. #UKLSHC,  #MedTech, #PharmasCommercialFunctions #endtoendtransformation, #collaboration, #partnerships. #connecteddevices, #IOMT, #AI, #GenAI, #onsurance. #healthinsurance #employers #employees John Haughey, James Gregson, Hanno Ronte,Elizabeth Hampson, Andy Masters Gareth Evans, Rob Hankey, Richard Baderman, Kathryn Thompson, Seb Burnett, Gabriele G. Vanoli,Susanne Uhlmann, Karen Ramsey, Anjan Roy, Ray Bigelow, Márcia Costa Emily May, Ditto Antony

60

Some hard truths from our Co-Founder & Chair, Prof. Ara Darzi, in his critical review of the NHS. The report raises urgent concerns affecting patient safety, resource management, and the overall effectiveness of our healthcare system. Key takeaways: - Re-energizing the workforce is crucial -Shifting more care from hospitals to communities is essential - We must be bolder in transitioning from sickness treatment to prevention https://lnkd.in/eAHY2RZP #NHSTransformation #PatientSafety #HealthcareInnovation #UrgentAction#NHS #Healthcare #PatientSafety #UrgentAction #ClinicalLeadership

5

I participated in a panel at the BMJ Future Health conference in London on health care technology and the digital divide. An invited commentary on this topic was published in JAMA Network Open this week, aptly leading with ‘From Innovation to Inclusion.’ Despite the drive to make care more accessible and transparent while promoting greater activation and self-efficacy for patients, there are issues with access to broadband and smartphones, and limited digital literacy. Digital activation is essential for equitable access to health care, though digital health developments far outpace efforts to bridge the digital divide. Indeed, with the disproportionate burden of chronic disease and illness borne by the most underserved and digitally excluded, it is imperative that digital health innovation and advocacy focus foremost on these patients. Success also depends heavily on a commitment from the technology sector, funding sources, and policymakers, else the digital divide will only grow wider. https://lnkd.in/eftMTxyh

3

Digital Health Unplugged Podcast: Why is the NHS so difficult to sell to? https://lnkd.in/emEnAtY6 Jordan Sollof, reporter at Digital Health News, is joined by Lloyd Price and Mohammad Al-Ubaydli to talk about procurement and why the NHS is so difficult to sell to. From their own experience, Price, a HealthTech founder, M&A advisor for Nelson Advisors and Non-Executive Director for various Digital Health companies, and Al-Ubaydli, Founder and Chief Executive of Digital Health social enterprise, Patients Know Best, shine a light on the main issues that can make selling to the NHS a challenge. The pair discuss success stories of startups which have successfully sold to the NHS, before assessing whether companies and suppliers need to take more care in ensuring they are pitching the right solution to the right organisation. They give their views on whether the NHS procurement process has become overcomplicated, a point raised in a session at Rewired 2024, and speculate whether the forthcoming Procurement Act (which was originally due to come into force in October 2024, but has been delayed until February 2025) will solve some issues and make it easier for those selling in the health technology sector. Finally, the guests predict what they anticipate will happen in the coming months and years, including whether the NHS will become a simpler system as a whole to sell to or if we will still be having the same conversation about difficulties selling in a few years’ time https://lnkd.in/emEnAtY6

14

4 Comments

Are value-based payments and equity at odds with one another? Early evidence on APM participation certainly seemed so, with greater participation in affluent areas. In what may be one of the first examples of an APM improving equity, we found that Medicare's CJR program actually mitigated disparities in post-surgical complications after hip/knee replacement for dual eligibles (vs. non-duals). This is welcome news with the upcoming TEAM model in 2026 that will once again scale bundles nationally on a mandatory basis. Important context however is that this does not suggest VBP or bundles are uniformly good for equity. For example, there is some evidence that hospitals in CJR were more likely to avoid surgery on Black beneficiaries. So we must interpret this new promising evidence on reduced SES outcome disparities in the context of the broader evidence. Austin Kilaru Joshua M. Liao The Parity Center https://lnkd.in/etMGw9-M

57

10 Comments

"Overall, advancing health equity remains a moderate to high priority for most organizations surveyed, with varying levels of investment, leadership, strategic maturity and capabilities to advance identified priorities," the EY 2024 Health Equity Outlook Report says. Significantly, the role of different organizations in health equity prioritization is underscored. Government organizations, especially federal bodies and those with over $1 billion in revenue and more mature health equity strategies are likely to report higher levels of health equity prioritization, highlighting their crucial role in this endeavor. Consistent with last year’s findings, the specific factors and issues prioritized within health equity programs are diverse. Health access and quality remain at the top—44% of organizations ranking it in their top three health equity priorities, up from 34% in 2023. Health equity strategy development was cited by roughly a third (34%), consistent with 2023 (33%). Another top area of focus cited was health outcomes disparity closure (31% of organizations). There was a significant—50%—increase in those citing data, AI, and technology as a priority. At the same time, a reduced focus was observed on healthcare costs and addressing upstream social determinants of health factors such as economic stability and inclusion, neighborhood and built environment, and broadband infrastructure and access. Access the report at https://lnkd.in/g9WhZeTc #Health #Healthequity #Healthdisparities #Publichealth #Healthcare #wellness #healthycommunities #healthequityforum #SDoH

3

Pleased to publish today in the New England Journal of Medicine, ‘Lessons from England’s National Health Service’ with Tim Ferris and David Blumenthal. Four key points to share ⬇️ 1. Recent NHS history suggests underinvestment can undermine even a high functioning health system. Austerity left the NHS vulnerable to demographic and technological trends and shocks like the pandemic that required reserves of capacity.  2. There are risks and benefits to having a centralised health system such as the NHS. Benefits include reduced costs (admin, drugs etc) and strong coordination of national strategy eg emergency response and exploiting tech opportunities. Risks are precipitous reorganisations. 3. The political temptation to embark on major NHS reorganisations has resulted in 8 in the last 30 years, increased cynicism and disengagement among the workforce, and huge avoidable cost.  4. Primary care in both the US and the UK is increasingly vulnerable to demographic pressures and private equity ownership. But it is critical infrastructure to the health system as a whole - ensuring it functions well needs far more attention by policymakers. Full article ⬇️  ££ https://lnkd.in/ejirantH 

147

6 Comments

Looking forward to attending this. The #digitaltransformation of health and care is complex. But our BCS, The Chartered Institute for IT expert members believe that with a coherent long term national strategy, it can be achieved.

2

Thanks Michael Chang for referencing this 2023 series from The Lancet. “Whilst Environmental, Social and Governance frameworks are increasingly used to guide more responsibe investment, they still lack specific health indicators. Health needs to become a crucial consideration of investor frameworks and global capital markets. Doing so will require the adoption of different economic models, new legislative and regulatory measures, civil society advocacy and accountability, and better corporate social responsibility.” This points to your work Matthew Morgan Quality of Life Foundation on Consistent evaluation of health and wellbeing outcomes in new homes and neighbourhoods https://lnkd.in/e5J_ce7K

6

5 Comments

💬 Why does rural healthcare lag behind urban counterparts in funding? Our blog "Fair Funding for Rural Areas" sheds light on the financial inequities affecting our healthcare system. Join the discussion on how to create a more balanced and fair funding model. 🔗 https://lnkd.in/ec7Zwxq9 #RuralHealthcare #FundingDisparity #NHSFunding #HealthcareEquity #RuralVsUrban #HealthcareFunding

2

Eóghan Forde, PhD Aridhia – Digital Research Environment – DRE thanks for posting. The Health Data Research UK (HDR UK) Lancet paper is a nice summary of some of the metrics and challenges associated with building a global network of scientists, clinicians, data scientists, data controllers willing (in principle) to share metadata and allow governed access to sensitive and privileged data resources. Nobody has enough data or the perfect repository. The real challenge is that the community wants to collaborate, share insights, models, results and allow approved access to data BUT are concerned about who, where and how those resources are being used, how they're governed and how the results can be validated and re-used. The answer as in the ICODA example from Health Data Research UK (HDR UK) is to use a Trusted Research Environment or in UK speak a Secure Data Environment. ICODA used the Aridhia – Digital Research Environment – DRE ,we have 15 Hubs across the world with data contributions from over 50 countries helping increase the diversity of data resources for pediatric medicine, multiple cancer sub-types, critical care research and neurodegenerative conditions for both clinical research and routing clinical care. Routine use of accredited TRE's/SDE's is key to removing the friction/wheel re-invention for trusted sharing or access to data and collaborative data science. See here for some further thoughts on formal accreditation of Trusted Research Environments to make discovery of data assets and collaboration safe, secure and productive https://lnkd.in/eWEV3aR8

9